Hagerty, Inc.
HGTY NYSE Insurance Agents, Brokers & Service Financials FY2020βFY2025
What Hagerty, Inc. does
No business description yet.
- Legal name
- Hagerty, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 26, 2026
- Accession Β· CIK
- 0001840776-26-000013
0001840776
Revenue and margins
Hagerty, Inc. had $1.5B of revenue in fiscal 2025, up 17.3% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $194M in fiscal 2025, 13.4% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Hagerty, Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 0.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Hagerty, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $275M | $95.2M | $119M | $179M | $160M |
| Debt incl. finance leases | $137M | $108M | $131M | $106M | $178M |
| Net debt / EBITDA | β11.5x | β | 0.2x | β0.7x | β |
| Debt / equity | β | 1.8x | 1.4x | 0.7x | 0.8x |
| Interest coverage | β | β | 1.9x | 47.6x | β |
| Current ratio | 1.8x | 1.4x | 1.5x | 0.9x | β |
| Quick ratio | 1.8x | 1.4x | 1.5x | 0.9x | β |
| Total assets | $1.0B | $1.3B | $1.6B | $1.7B | $2.1B |
| Total liabilities | $771M | $945M | $1.1B | $1.1B | $1.3B |
| Shareholders' equity | β$324M | $59.3M | $92.7M | $150M | $221M |
| Net debt (β = net cash) | β$139M | $13.1M | $11.4M | β$73.0M | $17.7M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β |
| F-score | β / 3 | 3 / 8 | 6 / 7 | 6 / 7 | 6 / 7 | β / 6 |
| Accruals ratio | β12.2% | β10.7% | β2.0% | β7.3% | β6.0% | β3.7% |
| Altman Z'' | 1.86 | 0.50 | β0.15 | 0.86 | β0.68 | β |
6 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | $500M | $619M | $788M | $1.0B | $1.2B | $1.5B |
| Operating income | $15.8M | β$10.1M | β$67.6M | $10.4M | $66.4M | β |
| Interest expense | β | β | β | $5.4M | $1.4M | $5.4M |
| Pretax income | $14.9M | β$54.6M | $11.1M | $44.8M | $93.7M | $139M |
| Income tax | $4.8M | $6.8M | $7.0M | $16.6M | $15.4M | β$10.0M |
| Net income | $10.2M | β$46.4M | $32.1M | $28.2M | $78.3M | $149M |
| Net income to common | β | β$46.4M | β$24.0M | β | β | β |
| Diluted EPS | $101.66 | β$0.56 | β | β | β | β |
| Diluted shares | 0.00B | 0.08B | β | β | β | β |
| Cash flow | ||||||
| Cash from operations | $84.6M | $42.3M | $55.3M | $134M | $177M | $219M |
| Capital expenditure | $38.3M | $43.4M | $44.4M | $26.4M | $21.3M | $24.5M |
| Free cash flow | $46.3M | β$1.1M | $11.0M | $107M | $156M | $194M |
| Depreciation and amortization | $11.8M | $22.1M | $33.9M | $45.8M | $38.9M | $37.5M |
| Stock-based compensation | β | $0.0M | $12.1M | $18.0M | $17.4M | $18.9M |
| Acquisitions | $8.9M | $14.6M | $15.4M | $8.7M | $25.1M | $1.6M |
| Balance sheet | ||||||
| Cash and short-term investments | $38.1M | $275M | $95.2M | $119M | $179M | $160M |
| Total debt | $70.0M | $137M | $108M | $131M | $106M | $178M |
| Current assets | $513M | $895M | $937M | $1.3B | $858M | β |
| Current liabilities | $385M | $496M | $667M | $842M | $915M | β |
| Inventory | β | β | $2.1M | $5.0M | $18.5M | $12.4M |
| Property and equipment, net | $25.8M | $28.4M | $25.3M | $20.8M | $18.2M | $16.3M |
| Goodwill | $4.7M | $11.5M | $115M | $114M | $114M | $114M |
| Intangible assets | $46.6M | $76.2M | $104M | $91.9M | $90.1M | $88.9M |
| Total assets | $611M | $1.0B | $1.3B | $1.6B | $1.7B | $2.1B |
| Total liabilities | $493M | $771M | $945M | $1.1B | $1.1B | $1.3B |
| Preferred stock | β | $0.0M | $0.0M | β | β | β |
| Shareholders' equity | β$0.0M | β$324M | $59.3M | $92.7M | $150M | $221M |
| Margins | ||||||
| Operating margin | 3.2% | β1.6% | β8.6% | 1.0% | 5.3% | β |
| EBITDA margin | 5.5% | 2.0% | β4.3% | 5.5% | 8.5% | β |
| Net margin | 2.0% | β7.5% | 4.1% | 2.7% | 6.3% | 10.2% |
| FCF margin | 9.3% | β0.2% | 1.4% | 10.4% | 12.5% | 13.4% |
| Returns | ||||||
| Return on capital | 33.6% | β | β60.7% | 6.5% | 71.8% | β |
| Return on capital employed | 7.0% | β1.8% | β10.5% | 1.4% | 8.4% | β |
| Return on equity | β | β | β | 37.1% | 64.4% | 80.3% |
| Return on assets | 1.7% | β5.6% | 2.7% | 1.9% | 4.7% | 7.8% |
| Return on tangible equity | β | β | β | β | β | 818.3% |
| Growth | ||||||
| Revenue growth | β | 23.9% | 27.2% | 30.4% | 20.9% | 17.3% |
| Net income growth | β | β556.0% | β | β12.2% | 177.9% | 90.6% |
| EPS growth | β | β100.6% | β | β | β | β |
| FCF growth | β | β102.4% | β | 879.7% | 45.1% | 24.9% |
| Share count change | β | 82,227.0% | β | β | β | β |
| Financial health | ||||||
| Net debt / EBITDA | 1.2x | β11.5x | β | 0.2x | β0.7x | β |
| Debt / equity | β | β | 1.8x | 1.4x | 0.7x | 0.8x |
| Interest coverage | β | β | β | 1.9x | 47.6x | β |
| Current ratio | 1.3x | 1.8x | 1.4x | 1.5x | 0.9x | β |
| Quick ratio | 1.3x | 1.8x | 1.4x | 1.5x | 0.9x | β |
| Capital allocation | ||||||
| Capex / revenue | 7.7% | 7.0% | 5.6% | 2.6% | 1.7% | 1.7% |
| Stock comp / revenue | β | 0.0% | 1.5% | 1.8% | 1.4% | 1.3% |
| Quality scores | ||||||
| Piotroski F-score | β | 3.0 | 6.0 | 6.0 | 6.0 | β |
| Altman Z'' | 1.9 | 0.5 | β0.1 | 0.9 | β0.7 | β |
| Accruals ratio | β12.2% | β10.7% | β2.0% | β7.3% | β6.0% | β3.7% |
Source: SEC EDGAR XBRL filings (CIK 0001840776). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.